Results 1 to 10 of about 55,383 (212)

Human parainfluenza virus surveillance in pediatric patients with lower respiratory tract infections: a special view of parainfluenza type 4

Jornal de Pediatria (Versão em Português), 2018
Objective: Characterize the role of human parainfluenza virus and its clinical features in Brazilian children under 2 years of age presenting with acute lower respiratory tract infections.
Luciano M. Thomazelli, Danielle B.L. de Oliveira, Giuliana S. Durigon, Brett Whitaker, Shifaq Kamili, Eitan N. Berezin, Edison L. Durigon   +6 more
doaj   +8 more sources

Identification of a natural human serotype 3 parainfluenza virus [PDF]

Virology Journal, 2011
Parainfluenza virus is an important pathogen threatening the health of animals and human, which brings human many kinds of disease, especially lower respiratory tract infection involving infants and young children.
Wang Xiao-Jing, Si Hong-Li, Bai Mu-Qun, Zhou Xu, Jiang Qing, Yang Hui-Ting, Lu Yan, Zhao Heng, He Hong-Bin, He Cheng-Qiang   +9 more
doaj   +4 more sources

Protective antibodies against human parainfluenza virus type 3 infection [PDF]

mAbs, 2021
Human parainfluenza virus type III (HPIV3) is a common respiratory pathogen that afflicts children and can be fatal in vulnerable populations, including the immunocompromised. There are currently no effective vaccines or therapeutics available, resulting
Jim Boonyaratanakornkit, Suruchi Singh, Connor Weidle, Justas Rodarte, Ramasamy Bakthavatsalam, Jonathan Perkins, Guillaume B.E. Stewart-Jones, Peter D. Kwong, Andrew T. McGuire, Marie Pancera, Justin J. Taylor   +10 more
doaj   +3 more sources

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1 [PDF]

Frontiers in Immunology, 2020
Human Parainfluenza Virus-3 (HPIV3) causes severe respiratory illness in immunocompromised patients and lacks approved anti-viral therapies. A phase I study of adoptively transferred virus-specific T-cells (VSTs) targeting HPIV3 following bone marrow ...
Katherine M. Harris, Katherine M. Harris, Sarah E. Horn, Melanie L. Grant, Haili Lang, Gelina Sani, Mariah A. Jensen-Wachspress, Vaishnavi V. Kankate, Anushree Datar, Christopher A. Lazarski, Catherine M. Bollard, Catherine M. Bollard, Catherine M. Bollard, Michael D. Keller, Michael D. Keller, Michael D. Keller   +15 more
doaj   +3 more sources

Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets

mBio, 2022
Human parainfluenza virus type 3 (HPIV-3) is a significant cause of lower respiratory tract infections, with the most severe disease in young infants, immunocompromised individuals, and the elderly.
Laurine C. Rijsbergen, Katharina S. Schmitz, Lineke Begeman, Jennifer Drew-Bear, Lennert Gommers, Mart M. Lamers, Alexander L. Greninger, Bart L. Haagmans, Matteo Porotto, Rik L. de Swart, Anne Moscona, Rory D. de Vries   +11 more
doaj   +5 more sources

Long-Term Trends in Human Parainfluenza Virus Types 1, 2, and 3 Infection in Korea (2007–2024) [PDF]

Pathogens
This study investigated the long-term trends in human parainfluenza virus (HPIV) types 1, 2, and 3 in Korea by year, age group, and season. A total of 23,284 nasopharyngeal swabs collected from patients with respiratory symptoms at a tertiary hospital in
Yu Jeong Kim, Jeong Su Han, Jae-Sik Jeon, Sung Hun Jang, Qianwen Wang, Jae Kyung Kim   +5 more
doaj   +2 more sources

The Clinical Performance of the BioCode Respiratory Pathogen Panel for the Detection of Viruses and Bacteria from Nasopharyngeal Swabs

Microbiology Spectrum, 2023
Early detection of microbial pathogens causing respiratory tract infection plays a crucial role in clinical management. The BioCode Respiratory Pathogen Panel (BioCode RPP) utilizes reverse transcriptase PCR (RT-PCR) in combination with barcoded magnetic
Xin Zhang, Colleen Knoth, Anh Pham, Amorce Lima, Rosario Dominguez, Irvin Ibarra-Flores, Juan C. Lopez, Dominic Uy, Suzane Silbert, Anami Patel, Michael Aye, Yi-Wei Tang, Jennifer Dien Bard   +12 more
doaj   +1 more source

CIRCULATING PATTERN OF RESPIRATORY VIRUSES, IN EGYPT, SEASON 2013-2014 [PDF]

Bulletin of Pharmaceutical Sciences. Assiut University, 2020
Respiratory viruses causes lower and upper respiratory tract infections; LRTIs and URTIs. These infections are from the predominant causes of infections, especially in children and infants.
Yara Shamikh, Ibrahim Elsayed, Amel Naguib, Wael Roshdy   +3 more
doaj   +1 more source

Exposure to Novel Parainfluenza Virus and Clinical Relevance in 2 Bottlenose Dolphin (Tursiops truncatus) Populations

Emerging Infectious Diseases, 2008
Parainfluenza virus (PIV) is a leading cause of respiratory infections in humans. A novel virus closely related to human and bovine parainfluenza viruses types 3 (HPIV-3 and BPIV-3), named Tursiops truncatus parainfluenza virus type 1 (TtPIV-1), was ...
Stephanie Venn-Watson, Rebecca Rivera, Cynthia R. Smith, Jeremiah T. Saliki, Shannon Caseltine, Judy A. St. Leger, Pam Yochem, Randall S. Wells, Hendrik Nollens   +8 more
doaj   +1 more source

Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea

Virology Journal, 2022
Background Since the onset of the coronavirus disease-2019 (COVID-19) pandemic, the prevalence of respiratory infectious diseases, particularly, the flu epidemic, has considerably decreased.
Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, Cheon Kwon Yoo, Eun-Jin Kim   +7 more
doaj   +1 more source